{
    "2020-01-20": [
        [
            {
                "time": "",
                "original_text": "东阳阳光药涨逾4% 三样产品中标国家药品集中采购",
                "features": {
                    "keywords": [
                        "东阳光药",
                        "中标",
                        "国家药品集中采购"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "港股医药股涨幅扩大，东阳光药大涨超12%",
                "features": {
                    "keywords": [
                        "港股",
                        "医药股",
                        "东阳光药"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "72股获杠杆资金大手笔加仓",
                "features": {
                    "keywords": [
                        "杠杆资金",
                        "加仓"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【华泰医药代雯团队】行业周报：第二轮集采落定，看好仿制药龙头估值修复",
                "features": {
                    "keywords": [
                        "华泰医药",
                        "第二轮集采",
                        "仿制药龙头",
                        "估值修复"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}